BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31589957)

  • 41. Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis.
    Sen S; Mandal P; Bhattacharya A; Kundu S; Roy Chowdhury R; Mondal NR; Chatterjee T; Chakravarty B; Roy S; Sengupta S
    Tumour Biol; 2017 May; 39(5):1010428317699799. PubMed ID: 28459195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.
    de Wilde J; Kooter JM; Overmeer RM; Claassen-Kramer D; Meijer CJ; Snijders PJ; Steenbergen RD
    BMC Cancer; 2010 Jun; 10():271. PubMed ID: 20534141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PAX1 methylation as a potential biomarker for cervical cancer screening.
    Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
    Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women].
    Niyazi M; Liu XW; Zhu KC
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):31-4. PubMed ID: 22490852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome.
    Lu X; Jiang L; Zhang L; Zhu Y; Hu W; Wang J; Ruan X; Xu Z; Meng X; Gao J; Su X; Yan F
    Neoplasia; 2019 Jun; 21(6):591-601. PubMed ID: 31055200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.
    Huang J; Luo JY; Tan HZ
    PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The detection of DNA methylation of tumour suppressor genes in cervical high-grade squamous intraepithelial lesion: A prospective cytological-histological correlation study of 70 cases.
    Ondič O; Němcová J; Alaghehbandan R; Černá K; Gomolčáková B; Kinkorová-Luňáčková I; Chytra J; Šidlová H; Májek O; Bouda J
    Cytopathology; 2019 Jul; 30(4):426-431. PubMed ID: 31074057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma.
    Wu MZ; Li WN; Cha N; Tian LX; Zhang YI; Wu X; Guo KJ; Wu GP
    Cell Transplant; 2018 Sep; 27(9):1401-1406. PubMed ID: 30056761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer.
    Sun C; Reimers LL; Burk RD
    Gynecol Oncol; 2011 Apr; 121(1):59-63. PubMed ID: 21306759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphisms and functional analysis of the intact human papillomavirus16 e2 gene.
    Ekalaksananan T; Jungpol W; Prasitthimay C; Wongjampa W; Kongyingyoes B; Pientong C
    Asian Pac J Cancer Prev; 2014; 15(23):10255-62. PubMed ID: 25556457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
    Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
    Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alteration of Human Papillomavirus Type 16 Genetic and Epigenetic Profiles in Cervical Cancer Patients Is Indicative of Poor Disease Prognosis: A Cohort Analysis.
    Dutta S; Singh RK; Mandal RK; Roychoudhury S; Basu P; Panda CK
    Int J Gynecol Cancer; 2016 May; 26(4):750-7. PubMed ID: 27051049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.
    Discacciati MG; Gimenes F; Pennacchi PC; Faião-Flores F; Zeferino LC; Derchain SM; Teixeira JC; Costa MC; Zonta M; Termini L; Boccardo E; Longatto-Filho A; Consolaro ME; Villa LL; Maria-Engler SS
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1539-47. PubMed ID: 26261088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma.
    Chang CC; Huang RL; Wang HC; Liao YP; Yu MH; Lai HC
    Int J Gynecol Cancer; 2014 Feb; 24(2):201-9. PubMed ID: 24407576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India.
    Kadian LK; Yadav R; Nanda S; Gulshan G; Sharma S; Yadav C
    Mol Biol Rep; 2020 Dec; 47(12):9725-9732. PubMed ID: 33230782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The CpG island methylator phenotype increases the risk of high-grade squamous intraepithelial lesions and cervical cancer.
    Loaeza-Loaeza J; Illades-Aguiar B; Del Moral-Hernández O; Castro-Coronel Y; Leyva-Vázquez MA; Dircio-Maldonado R; Ortiz-Ortiz J; Hernández-Sotelo D
    Clin Epigenetics; 2022 Jan; 14(1):4. PubMed ID: 34991696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas.
    Barbieri D; Nebiaj A; Strammiello R; Agosti R; Sciascia S; Gallinella G; Landini MP; Caliceti U; Venturoli S
    J Clin Virol; 2014 Jul; 60(3):243-9. PubMed ID: 24845262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined clinical and genetic testing algorithm for cervical cancer diagnosis.
    Liou YL; Zhang TL; Yan T; Yeh CT; Kang YN; Cao L; Wu N; Chang CF; Wang HJ; Yen C; Chu TY; Zhang Y; Zhang Y; Zhou H
    Clin Epigenetics; 2016; 8():66. PubMed ID: 27293491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.